Langer, Ciechanover godfather the latest AI upstart; Ipsen forges $446M AML development pact
There’s a new AI player jumping into the drug discovery game. And they have some high-powered scientific advisors in their corner.
Tel Aviv-based Quris has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
